Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Effects of Low-dose S-Ketamine on Incidence of Postpartum Depression in Parturients With Prenatal Depression: A Randomized, Double-blind, Placebo-controlled Trial


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03927378

Organisation Name: Peking University First Hospital

Overal Status: Recruiting

Start Date: June 19, 2020

Last Update: June 23, 2020

Lead Sponsor: Peking University First Hospital

Brief Summary: Postpartum depression is common in mothers early after childbirth and produces harmful effects not only on mothers, but also on infants and young children. Parturients with prenatal depression are at increased risk of postpartum depression. Low-dose s-ketamine can be used for antidepressant therapy. We hypothesize that low-dose s-ketamine has a therapeutic effect on parturients with prenatal depression. This study is designed to investigate whether low-dose s-ketamine administered after childbirth can reduce the incidence of postpartum depression in parturients with prenatal depression.

Conditions:
  • Perinatal Depression
  • Ketamine
  • Postpartum Depression


Total execution time in seconds: 0.20077204704285